Rock Springs Capital Management LP Axogen, Inc. Transaction History

Rock Springs Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $7.3 Million - $12.4 Million	-603,970 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $1.03 Million - $2.31 Million	60,496 Added 11.13%	603,970 $12.3 Million
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $51,960 - $85,303	-1,526 Reduced 0.28%	543,474 $20 Million
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $1.45 Million - $2.1 Million	40,000 Added 7.92%	545,000 $27.4 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $671,000 - $1.11 Million	27,500 Added 5.76%	505,000 $18.4 Million
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $1.43 Million - $2.22 Million	77,500 Added 19.38%	477,500 $13.5 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $5.86 Million - $7.74 Million	400,000	400,000 $7.74 Million

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.